Dyno Therapeutics
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1 Kendall Sq Bldg 1400e Ste 202, Cambrid...Website
www.dynotx.comRevenue
$23 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Dyno Therapeutics
Dyno Therapeutics is a pioneer in applying artificial intelligence (AI) and quantitative high-throughput in vivo experiments to gene therapy. The company's proprietary CapsidMap platform rapidly discovers and systematically optimizes Adeno-Associated Virus (AAV) capsid vectors that significantly outperform current approaches for in vivo gene delivery, thereby expanding the range of diseases treatable with gene therapies. Dyno was founded in 2018 and is located in Cambridge, Massachusetts.Explore more
Dyno Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dyno Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Dyno Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Dyno Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Dyno Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Dyno Therapeutics
Product Launch: Get notified when Dyno Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Dyno Therapeutics has new funding data
Click to see if Dyno Therapeutics had a recent Job posting/layoffs
Check out if Dyno Therapeutics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Dyno Therapeutics
Compare insights from companies similar to Dyno Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
Company Profile Activity
Activity Insights
Dyno Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Dyno Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Dyno Therapeutics.
Dyno Therapeutics financials insights
Gather financial insights about Dyno Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$100M
Dyno Therapeutics Tech Stack
A closer look at the technologies used by Dyno Therapeutics
Most Recent Scoops
Hiring Plans
Dyno Therapeutics is hiring in Engineering & Technical for the first time in 12 months.
Hiring Plans
Person-Based
Research & Development
Person-Based
Product Launch, Pharmaceuticals, Artificial Intelligence
Person-Based
Bioengineering, Medical Research
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Dyno Therapeutics News & Media
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics announces inaugural 2025 Genetic Agency Technology Conference and launch of Dyno Frontiers ProgramDyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics to present breakthrough data on AAV gene delivery to the CNS, eye, and muscle at the 28th Annual ASGCT MeetingDyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics announces exercise of option by Roche for next-generation AAV vector for neurological gene therapyDyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
WATERTOWN, Mass.--(BUSINESS WIRE)--New strategic partnership leverages the power of Dyno’s platform, enabling Roche to advance next-generation AAV gene therapies across multiple targets
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Dyno Therapeutics
Sign Up For FreeTo access detailed company insights
Dyno Therapeutics is a pioneer in applying artificial intelligence (AI) and quantitative high-throughput in vivo experiments to gene therapy. The company's proprietary CapsidMap platform rapidly discovers and systematically optimizes Adeno-Associated Virus (AAV) capsid vectors that significantly outperform current approaches for in vivo gene delive... Read More
